Detalhe da pesquisa
1.
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic.
Immunity
; 55(10): 1764-1778, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049482
2.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Nature
; 601(7891): 110-117, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758478
3.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Nature
; 584(7821): 457-462, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668444
4.
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients.
Hepatology
; 74(1): 200-213, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249625
5.
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization.
Int J Mol Sci
; 23(18)2022 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36142588
6.
Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
J Virol
; 93(4)2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518652
7.
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
Gastroenterology
; 155(1): 180-193.e6, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550589
8.
Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'.
J Hepatol
; 79(5): e202-e204, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307998
9.
Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease.
J Hepatol
; 67(3): 490-500, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28483682
10.
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.
PLoS Pathog
; 10(6): e1004210, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24967632
11.
Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.
J Virol
; 88(2): 1332-41, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24227846
12.
Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity.
J Immunol
; 191(8): 4010-9, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24058176
13.
IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells.
J Immunol
; 190(7): 3142-52, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23447689
14.
Reduction of HBV replication prolongs the early immunological response to IFNα therapy.
J Hepatol
; 60(1): 54-61, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23994382
15.
Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases.
Eur J Immunol
; 43(4): 1109-20, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23280567
16.
Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.
Gastroenterology
; 143(3): 637-645, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22710188
17.
Protocol to detect antigen-specific nasal-resident T cells in humans.
STAR Protoc
; 4(1): 101995, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602901
18.
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans.
PLoS Pathog
; 6(8): e1001051, 2010 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-20808900
19.
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells.
Immunother Adv
; 2(1): ltab026, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35919490
20.
T cell immunity is key to the pandemic endgame: How to measure and monitor it.
Curr Res Immunol
; 3: 215-221, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065205